1. Home
  2. INBS vs TOVX Comparison

INBS vs TOVX Comparison

Compare INBS & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBS
  • TOVX
  • Stock Information
  • Founded
  • INBS 2016
  • TOVX 2001
  • Country
  • INBS United States
  • TOVX United States
  • Employees
  • INBS N/A
  • TOVX N/A
  • Industry
  • INBS Medical Specialities
  • TOVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INBS Health Care
  • TOVX Health Care
  • Exchange
  • INBS Nasdaq
  • TOVX Nasdaq
  • Market Cap
  • INBS 6.4M
  • TOVX 7.3M
  • IPO Year
  • INBS N/A
  • TOVX 2006
  • Fundamental
  • Price
  • INBS $0.69
  • TOVX $0.24
  • Analyst Decision
  • INBS
  • TOVX Hold
  • Analyst Count
  • INBS 0
  • TOVX 1
  • Target Price
  • INBS N/A
  • TOVX N/A
  • AVG Volume (30 Days)
  • INBS 265.2K
  • TOVX 4.6M
  • Earning Date
  • INBS 11-12-2025
  • TOVX 11-12-2025
  • Dividend Yield
  • INBS N/A
  • TOVX N/A
  • EPS Growth
  • INBS N/A
  • TOVX N/A
  • EPS
  • INBS N/A
  • TOVX N/A
  • Revenue
  • INBS $3,292,042.00
  • TOVX N/A
  • Revenue This Year
  • INBS $778.48
  • TOVX N/A
  • Revenue Next Year
  • INBS N/A
  • TOVX N/A
  • P/E Ratio
  • INBS N/A
  • TOVX N/A
  • Revenue Growth
  • INBS 3.26
  • TOVX N/A
  • 52 Week Low
  • INBS $0.64
  • TOVX $0.20
  • 52 Week High
  • INBS $2.75
  • TOVX $2.08
  • Technical
  • Relative Strength Index (RSI)
  • INBS 30.21
  • TOVX 40.04
  • Support Level
  • INBS $0.64
  • TOVX $0.20
  • Resistance Level
  • INBS $0.69
  • TOVX $0.30
  • Average True Range (ATR)
  • INBS 0.05
  • TOVX 0.02
  • MACD
  • INBS 0.00
  • TOVX -0.00
  • Stochastic Oscillator
  • INBS 17.04
  • TOVX 32.29

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: